Published in Tex Heart Inst J on January 01, 2013
Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol (1995) 5.51
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med (2004) 4.05
Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology (2012) 3.48
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM (1998) 2.81
Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol (2004) 1.70
Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr Pharm Des (2008) 1.55
Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol (1987) 1.49
Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. Am J Cardiol (1983) 1.48
The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL). Blood (2004) 1.30
Digoxin sensitivity in amyloid cardiomyopathy. Circulation (1981) 1.28
Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death. Heart Rhythm (2007) 1.24
Amyloidosis: a convoluted story. Br J Haematol (2001) 1.20
Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy. Hematology Am Soc Hematol Educ Program (2010) 1.20
Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents. Am J Cardiol (1985) 1.09
Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry. N Engl J Med (1987) 1.06
Diflunisal for ATTR cardiac amyloidosis. Congest Heart Fail (2012) 0.99
Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities. J Am Coll Cardiol (1984) 0.98
Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis. Am J Cardiol (1997) 0.88
Symptomatic conduction system disease in cardiac amyloidosis. Am J Cardiol (1997) 0.84